BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23915741)

  • 41. Historical perspective on hormonal therapy of advanced breast cancer.
    Jordan C
    Clin Ther; 2002; 24 Suppl A():A3-16. PubMed ID: 11911507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.
    Kaklamani VG; Gradishar WJ
    Oncologist; 2017 May; 22(5):507-517. PubMed ID: 28314835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.
    Aiello Bowles EJ; Boudreau DM; Chubak J; Yu O; Fujii M; Chestnut J; Buist DS
    J Oncol Pract; 2012 Nov; 8(6):e149-57. PubMed ID: 23598850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of endocrine options for the treatment of advanced breast cancer.
    Kaufmann M
    Oncology; 1997; 54 Suppl 2():2-5. PubMed ID: 9394852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone therapy and breast cancer: a review].
    Lucchi-Angellier E
    Rev Med Interne; 2001 Dec; 22(12):1213-24. PubMed ID: 11794892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocrine therapy of breast cancer.
    Lumachi F; Luisetto G; Basso SM; Basso U; Brunello A; Camozzi V
    Curr Med Chem; 2011; 18(4):513-22. PubMed ID: 21143113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of endocrine therapy for metastatic breast cancer.
    Kimmick G; Muss HB
    Oncology (Williston Park); 1995 Sep; 9(9):877-86, 889-90; discussion 892-4. PubMed ID: 8562327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].
    Bak AM; Laursen BE; Rungby J; Brock B
    Ugeskr Laeger; 2011 Feb; 173(9):648-51. PubMed ID: 21362392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Summary of aromatase inhibitor trials: the past and future.
    Goss P; von Eichel L
    J Steroid Biochem Mol Biol; 2007; 106(1-5):40-8. PubMed ID: 17627816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspective.
    Jordan VC; Knudson AG
    Oncology (Williston Park); 2006 May; 20(6):553-62; discussion 567-8, 573, 577. PubMed ID: 16773843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocrine therapies of breast cancer.
    Goldhirsch A; Gelber RD
    Semin Oncol; 1996 Aug; 23(4):494-505. PubMed ID: 8757275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endocrine therapy of advanced breast cancer.
    Rose C; Mouridsen HT
    Acta Oncol; 1988; 27(6A):721-8. PubMed ID: 3064777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.
    Senn HJ; Thürlimann B; Goldhirsch A; Wood WC; Gelber RD; Coates AS
    Breast; 2003 Dec; 12(6):569-82. PubMed ID: 14659136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocrine therapy of metastatic breast cancer.
    Rodríguez Lajusticia L; Martín Jiménez M; López-Tarruella Cobo S
    Clin Transl Oncol; 2008 Aug; 10(8):462-7. PubMed ID: 18667376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Follow-up in breast carcinoma].
    Sinha C; Köhler H; Fink D
    Praxis (Bern 1994); 2008 Dec; 97(25):1321-8; quiz 1329-30. PubMed ID: 19085842
    [No Abstract]   [Full Text] [Related]  

  • 57. The fight against tamoxifen resistance in breast cancer therapy: a new target in the battle?
    Nichols M
    Mol Interv; 2007 Feb; 7(1):13-6. PubMed ID: 17339602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequencing of aromatase inhibitors.
    Bertelli G
    Br J Cancer; 2005 Aug; 93 Suppl 1(Suppl 1):S6-9. PubMed ID: 16100523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
    Leary A; Dowsett M
    Br J Cancer; 2006 Sep; 95(6):661-6. PubMed ID: 16926831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihormone therapy in recurrent metastatic breast cancer.
    Pritchard KI
    JAMA; 2008 Jun; 299(23):2745; author reply 2745. PubMed ID: 18559999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.